AA

Anoop Agarwal

Active Director Director DIN 08299226
DIN 08299226 First appointment Dec 2018 Primary industry Consumer Goods
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2018
Shareholding value •••• Premium profile

About Anoop Agarwal

Data last updated:

Anoop Agarwal is a Director at Auckmed Pharma Private Limited (since 2018). The company operates in Consumer Goods. Auckmed Pharma Private Limited reported revenue of ₹1.39 Cr (FY 2025).

DIN 08299226
Primary Designation Director
Industry Consumer Goods
First Appointment 10 Dec 2018
Oldest Company Age 7 yrs
Largest company Auckmed Pharma Private Limited · ₹1.39 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Auckmed Pharma Private Limited U24299UP2018PTC111060
Director10 Dec 20182018₹1.39 Cr (FY 2025)Active

Board colleagues of Anoop Agarwal

NameDINCompanyDesignation
Bhagat Singh09534561Auckmed Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Auckmed Pharma Private Limited
Premium access

Shareholding and investment profile for Anoop Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anoop Agarwal

Anoop Agarwal currently holds 1 directorship: Auckmed Pharma Private Limited (Director, since 10 Dec 2018, revenue ₹1.39 Cr (FY 2025)).

Anoop Agarwal was first appointed on 10 Dec 2018 as Director at Auckmed Pharma Private Limited.

The current boards of Anoop Agarwal's companies include Bhagat Singh (Auckmed Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available